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Abstract 15 
Post-partum uterine inflammation (endometritis) in the dairy cow is associated with lower 16 
fertility at both the time of infection and after the inflammation has resolved. We 17 
hypothesized that aberrant DNA methylation may be involved in the sub-fertility associated 18 
with uterine inflammation. The objective of this study was to characterize genome-wide 19 
DNA methylation and gene expression in the endometrium of dairy cows with sub-clinical 20 
endometritis (SCE). Endometrial tissues were obtained at 29 days post-partum (n=12) and 21 
microarrays were used to characterize transcription and DNA methylation. Analyses 22 
revealed 1,856 probes differentially expressed in animals with SCE (n=6), compared with 23 
controls (CON, n=6, P<0.05, Storey Multiple testing correction) and 2,976 probes with 24 
significant correlation between gene expression and bacteriology score. No significant 25 
associations among DNA methylation and gene expression were detected. Analysis of 26 
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transcription data using GeneGo Metacore and Gene Set Enrichment Analysis identified 27 
several pathways and processes enriched in SCE cows, with the majority related to the 28 
immune response. Further, the top ontology terms enriched in genes that had expression 29 
data correlated to bacteriology score were: Defence response, inflammatory response, and 30 
innate immune response. Gene expression profiles in cows with subclinical endometritis in 31 
this study indicate that the immune response is activated, potentially resulting in a local pro-32 
inflammatory environment in the uterus. If this period of inflammation is prolonged it could 33 
result in tissue damage or failure to complete involution of the uterus, which may create a 34 
sub-optimal environment for future pregnancy.  35 
Introduction 36 
Uterine infection following parturition is a common cause of sub-fertility in dairy cows (11, 37 
40, 58). Infection resulting from microorganisms entering the uterus can result in an 38 
inflammatory state that, if left unresolved, can negatively affect subsequent reproductive 39 
performance.  Following parturition, the uterus undergoes a period of extensive remodelling 40 
or involution. Involution involves physical shrinkage of the uterus, followed by necrosis and 41 
sloughing of the caruncules, and lastly regeneration of the endometrium. During the early 42 
stages of involution, the uterus has a disrupted epithelial surface, coupled with fluid and 43 
tissue debris that support bacterial growth (32). Structural and functional effects of bacterial 44 
infection on the endometrium likely contribute to reduced fertility. Other causes of post-45 
partum inflammation include those resulting from systemic metabolic perturbation during 46 
the transition period. During the early post-partum period dairy cows undergo a period of 47 
negative energy balance (51). There is some evidence that this negative energy balance is 48 
associated with reduced immune function and increased inflammation in the uterus (23, 68, 49 
69).  50 
Failure to resolve postpartum uterine inflammation, an endometritis, can delay uterine 51 
involution and reduce reproductive function, including: suppression of hypothalamic 52 
gonadotropic secretion, follicular growth and function, and ovulation, as well as reduced 53 
conception and pregnancy rates (7, 33, 34). Furthermore, even sub-clinical endometritis, 54 
defined as inflammation of the uterus without clinical signs of endometritis, is negatively 55 
associated with subsequent reproductive performance (6, 21, 27).   56 
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Many transcriptional changes occur in the uterus during involution and these are likely 57 
regulated by epigenetic mechanisms (67). Epigenetic mechanisms such as DNA methylation 58 
regulate gene expression and, subsequently, phenotype without changing the underlying 59 
DNA sequence. There is compelling evidence that variation in the immune response in cattle 60 
is epigenetically regulated (22, 54). Further, we have previously reported an association 61 
between DNA methylation and gene expression in the endometrium during early pregnancy 62 
(65).  Therefore it was hypothesized that prolonged post-partum uterine inflammation may 63 
be the result of maladaptive DNA methylation of inflammatory mediators. If this epigenetic 64 
landscape persists, it could explain the sub-fertility associated with post-partum 65 
inflammation. 66 
To understand the molecular mechanisms regulating post-partum inflammation, we 67 
characterized gene expression in the endometrium of animals with or without a post-68 
partum uterine inflammation.. Furthermore, it was hypothesized that aberrant DNA 69 
methylation may be involved in the sub-fertility associated with post-partum uterine 70 
inflammation. To test this hypothesis, genome wide gene expression and DNA methylation 71 
were characterized in the uterus of dairy cows with and without sub-clinical endometritis at 72 
29 days post-partum. 73 
Methods 74 
Animal trial 75 
All procedures were undertaken with the approval of the Ruakura Animal Ethics Committee 76 
(Hamilton, New Zealand). The experiment was undertaken at Scott Farm (37°45.952’S, 77 
175°21.835’E; DairyNZ Ltd, Hamilton, New Zealand) using 109 cows. All cows grazed pasture 78 
and were managed in an intensive rotational grazing manner (47). Cows in both groups 79 
were matched for calving date, breed and age. Those with calving difficulties or retained 80 
placenta, or that had been treated with antibiotics during the first 30 days post-partum, 81 
were excluded from the study.  82 
 83 
Uterine sampling and polymononuclear cell counts 84 
Uterine sampling was undertaken between 22 and 25 days post-partum. Prior to uterine 85 
samples being collected, the vulva was cleaned. Collection of uterine samples for evaluation 86 
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of polymorphonuclear (PMN) cells and uterine bacteriology was undertaken as described 87 
previously (47) using pap endocervical sample brush (cyto-brush, Ebos Group Ltd, 88 
Christchurch, New Zealand). The sterile cyto-brush was mounted on to a sterile stillette 89 
(length: 500 mm; internal dia. 5.0 mm; external dia. 7.0 mm). The stillette and cyto-brush 90 
were protected by a cannula, which in turn, was protected by a plastic sleeve. The cannula 91 
was inserted into the uterus via the cervix. Once in the lumen of the uterus the cyto-brush 92 
was passed through the plastic sleeve and rotated a quarter turn while in contact with the 93 
endometrium. The cyto-brush was retracted into the cannula tip before withdrawal from 94 
the uterus, cervix and vagina. The brush was smeared onto a slide that was air dried and 95 
stained with Diff-Quik® Stain (Dade Behring, Newark, DE, USA.) within 1 h of sample 96 
collection. Cytological examination was completed within 24 to 48 h. More than 100 97 
nucleated cells were assessed and the percentage that was PMN and macrophages were 98 
recorded.  99 
 100 
Bacteriology 101 
Bacteriology was performed as previously described (39). Briefly, a cytobrush (Pap 102 
endocervical sample brush, Ebos Group Ltd, Christchurch, New Zealand) was used to collect 103 
uterine samples for bacteriology analyses at the same time as uterine cytology was 104 
performed. The cytobrush sample was then placed in Stuart Transport media (Copan Ames 105 
without charcoal, Oxoid, Basingstoke, UK). The cytobrush was removed from the transport 106 
media within an anaerobic chamber (80% N2, 10% CO2, and 10% H2 atmosphere; Coy 107 
Laboratory Products, Grass Lake, MI, USA) and streaked across two 0.1% esculin, 5% sheep 108 
blood agar plates (Fort Richard, Auckland, New Zealand). One plate was then removed and 109 
incubated aerobically. The end of the cytobrush was then snapped off and immersed in a 110 
fastidious anaerobic broth (Fort Richard, Auckland, New Zealand).  Bacterial growth was 111 
assessed after 2 and 5 d of incubation at 37 °C in the aerobic and anaerobic environments, 112 
respectively. Colony morphology, size, hemolysis patterns, pigmentation, opacity, and 113 
consistency were assessed, and each colony type was Gram-stained and cell morphology 114 
examined. Further biochemical tests were undertaken as required, using established 115 
techniques (35, 39). Gram positive cocci were assessed using catalase and esculin tests. 116 
Gram negative rods were evaluated with catalase, lactose, OUMI, and triple iron sugar tests. 117 
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The Gram positive coccibacillus were evaluated using catalase, maltose, mannitol, raffinose, 118 
and gelatin tests. Each isolate was subcultured to ensure a pure growth and a number of 119 
colonies were placed into 2 mL brain heart infusion broth supplemented with 20% glycerol 120 
and preserved at −20 °C. 121 
The DNA was extracted from the fastidious anaerobic broth that had bacterial growth, using 122 
the procedure for Gram negative bacteria, as per the manufacturer’s instruction (Wizard 123 
Genomic DNA purification kit, Promega, Madison, WI, USA). This DNA was then analyzed by 124 
PCR using primers designed to detect Prevotella spp. (71) and Fusobacterium spp. (45). 125 
A bacterial score was calculated based on growth in each of the 9 culture conditions, with a 126 
maximum score of 9 for cows that had growth in every type of culture (39). 127 
Blood sampling  128 
Blood was collected from the cows on day of euthanasia using coccygeal venipuncture into 129 
vacutainer tubes and immediately placed in iced water. The blood samples were centrifuged 130 
within 30 min (12 min at 1,500 x g) and the aspirated plasma fractions were stored at -20°C.  131 
Progesterone assay 132 
Progesterone was measured in plasma using a commercial kit (Progesterone Coat-A-Count; 133 
Siemens, Los Angeles, CA). The average intraassay coefficients of variation for the high and 134 
low controls were 5.91% and 3.14%, respectively, and the minimum detectable level was 135 
0.037 ng/mL.  136 
Selected CON and SCE cows 137 
The criteria for cow selection were based on the uterine swab samples. CON had no PMN or 138 
macrophages whereas SCE had > 18 % PMN cells (17) with an absence of macrophages. 139 
Cows were allocated to CON and SCE pairs balanced for calving date, breed, and age. A total 140 
of 12 cows (CON n=6; SCE n=6) between 27 and 31 days post-partum were sampled in the 141 
study. Cows were slaughtered at a commercial abattoir, and blood samples and tissues were 142 
collected  (42). 143 
Milk yield, composition and body condition 144 
 6 
 
Milk yield (kg/d) was measured twice daily using the DeLaval Harmony and ALPRO® milking 145 
system. Milk composition was determined weekly using infrared analysis (FT120m, Foss 146 
Electric, Hillerød, Denmark) and somatic cell number was determined using an electronic 147 
flurometric cell-counting technique (Fossomatic, Foss Electric, Hillerød, Denmark) by LIC Ltd 148 
(Hamilton, NZ). Individual body condition and body weight were measured at 3 time points 149 
post-calving (1, 2 and 3 weeks). Body condition was measured on the 10 point scale 150 
developed by Roche et al 2004, where 1 is emaciated and 10 obese (50). 151 
Plasma metabolites 152 
Plasma samples were analysed for blood metabolites using colorimetric techniques at 37°C 153 
with a Hitachi Modular P800 analyzer (Roche Diagnostics, Indianapolis, IN) as described 154 
previously (52). Briefly, the concentration of non-esterified fatty acids (NEFA, WAKO, Osaka, 155 
Japan), Magnesium (xlidyl blue reaction), albumin (bromocresol green reaction), total 156 
protein (Biuret reaction method) and globulin (calculated by subtracting the albumin value 157 
from the total protein value) were measured. Glutamate dehydrogenase (catalysing activity 158 
of NADH-dependent conversion of α-ketoglutarate to glutamate) and aspartate 159 
aminotransferase (catalysing activity of transamination of L-aspartate to oxaloacetate) were 160 
also measured. The inter-assay and intra-assay CV for all assays were ≤11% and ≤2%, 161 
respectively. 162 
Tissue sampling 163 
Cows were slaughtered and within 40 minutes of exsanguination, their reproductive tracts 164 
were recovered and stored on dry ice for inspection and dissection as follows. Excessive 165 
connective tissues were removed from the reproductive tract and the uterine horns were 166 
separated. Each uterine horn was dissected separately, and any abnormalities noted. 167 
Caruncular and intercaruncular endometrial tissue was sampled from the middle section of 168 
each uterine horn. Samples (between 0.5 to 1.0 g) were immediately transferred into cryo-169 
tubes and frozen in liquid nitrogen before storage at -80°C within 70 min of exsanguination. 170 
A complete cross-section was placed in neutral buffered formalin (4% w/v; Ajax Finechem 171 




Sections of caruncular endometrium were examined to determine the degree of 174 
inflammation at the time of tissue sampling. Paraffin-embedded uterine tissues were 175 
sectioned at 4-8 µm thickness, deparaffinised with xylol and stained with Haematoxylin and 176 
Eosin (H&E). The slides were incubated in double strength Gills Haemotoxylin for 3 minutes 177 
and washed with running tap water. They were then dipped in acid alcohol (1%) twice, 178 
rinsed in running tap water, and incubated in Scotts tap water substitute for 3 seconds 179 
followed by 5 minutes in running tap water. Slides were stained in aqueous Eosin (2%) for 3 180 
minutes, rinsed in tap water and drained. The samples were then dehydrated through 95% 181 
and 100% ethanol three times, dipped in xylol three times, and mounted with resin and a 182 
coverslip. Slides were left to harden overnight and sent to Gribbles Veterinary (Auckland, 183 
New Zealand) for inflammatory scoring.  184 
The tissues were assessed using the criteria described by Bonnet et al (9, 10) with some 185 
modifications. Epithelial and stratum compactum inflammatory cells were measured at 186 
number per number of 400X fields assessed; epithelium was only reviewed in areas where 187 
epithelium was at least partly or closely attached. Up to ten representative (every other 188 
contiguous) 400X fields of stratum compactum were reviewed per section.  189 
RNA extraction 190 
Endometrial tissues were homogenized in Qiagen buffer RLT (Qiagen GmbH, Qiagen Strasse 191 
1, 40724 Hilden, Germany) using a TissueLyser II (Qiagen).  Approximately 30 mg of tissue 192 
was homogenized for 2 minutes with three ball bearings of 1/8 inch diameter (Farrell 193 
Bearings, Hamilton, NZ) in a tube containing RLT lysis buffer (Qiagen). Total RNA was 194 
extracted using a Qiagen RNeasy kit (Qiagen). RNA quantity was determined by 195 
spectrophotometry using a Nanodrop ND-1000 (Nanodrop Technologies, Wilmington, DE). 196 
RNA integrity was assessed with a RNA 6000 Nano LabChip kit using the Agilent 2100 197 
Bioanalyzer (Agilent Technologies, Palo Alto, CA). All samples had an RNA integrity number 198 
above 7. 199 
Gene expression microarray  200 
RNA (150 ng) were amplified using the Agilent Low Input Quick Amp Labeling Kit, two color 201 
(Agilent, G2519F) to generate fluorescent complimentary RNA (cRNA) according to the 202 
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manufacturer’s instructions. cRNA quantity was measured by spectrophotometry using a 203 
ND-1000 (Nanodrop Technologies, Wilmington, DE). Cy3 and Cy5 labeled cRNA (825 ng) 204 
were added to Agilent 4x44k 60-mer oligonucleotide microarrays (G2519F 023647) and 205 
hybridized overnight at 65°C (17 hours). Slides were then washed with Agilent Gene 206 
Expression Wash Buffers 1 and 2 according to manufacturer’s instructions, inserted into a 207 
slide cover with ozone barrier, and scanned on an Agilent C scanner at 5µm.  208 
Hybridization design  209 
A total of 24 microarrays were used in this study, one for each tissue type among the 12 210 
animals. A reference sample was prepared from equal amounts of RNA from the 24 211 
endometrial samples analyzed in this study. This pooled sample was used as a ‘reference’ 212 
within each array hybridization. The reference sample was labeled with the Cy3 NHS ester 213 
dye, while each individual sample was labeled with the Cy5 NHS ester dye.  214 
Data analysis and statistics 215 
Agilent feature extraction software version 10.7.3.1 (Agilent Technologies, Palo Alto, CA, 216 
USA) was used to analyze the scanned Agilent microarray. The 24 scanned microarray image 217 
files were uploaded to the feature extraction software. Using a design file (023647), the 218 
feature extraction software locates features and converts the extracted data from each 219 
feature into a quantitative log2ratio. This software removes pixel outliers, performs 220 
statistical tests on the non-outlier pixels, subtracts background from features and flags any 221 
outlier features. The software was then used to perform LOWESS (locally weighted linear 222 
regression analysis) dye normalization and to calculate a p-value for each feature. 223 
Data analysis was performed on Genespring GX 12.5 (Agilent Technologies, Palo Alto, CA, 224 
USA). Microarray data were imported into Genespring using Agilents Data Import Wizard for 225 
Agilent Two Color Expression Data. Filters applied to the data to improve the quality of the 226 
normalized dataset included: firstly, filtering ‘on flags’ to ensure any probes that were not 227 
deemed ‘Detected’ (according to feature extraction spot quality guidelines) in at least 100% 228 
of at least one experimental group were omitted from analysis; secondly, probes were 229 
filtered on raw intensity units using the default setting (lower cutoff: 20th percentile and 230 
upper cutoff: 100th percentile). Probes that were not within this range in 100% in at least 231 
one experimental sample group were excluded. After quality control filtering 26,026 probes 232 
remained and were used for analysis. Comparisons among experimental groups (CON and 233 
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SCE) were undertaken using ANOVA, with significance thresholds set at P<0.05; multiple 234 
testing correction (Storey) was also applied. Gene expression data were also analyzed for 235 
association of gene expression and bacteriology score. A linear regression analysis was used 236 
to test for any associations, including Benjamini-Hochberg multiple testing correction. The 237 
microarray data were uploaded to NCBI Gene expression omnibus (GSE58794). For probes 238 
that were not annotated, full length transcripts were identified, where possible, by querying 239 
microarray probe sequences against the bovine genome (Btau5.1) using NCBI BLAST 240 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi). 241 
Gene function and pathway identification 242 
Functional analysis was performed using MetaCore (GeneGo Inc) GSEA (Gene set 243 
enrichment analysis and DAVID (Database for Annotation, Visualisation, and Integrated 244 
Discovery) (60). Gene lists containing differentially expressed genes for each comparison 245 
tested in the ANOVA were used for analyses with MetaCore to identify significantly enriched 246 
pathway maps. All entities in the microarray were used for GSEA analysis. GSEA ranks genes 247 
based on the correlation between their expression and the class distinction. Given an a 248 
priori defined set of genes, GSEA determines whether the members of the gene set are 249 
randomly distributed throughout the ranked gene list or are primarily found at the top or 250 
bottom of the list. An enrichment score (ES) is calculated that reflects the degree to which 251 
the gene set is overrepresented. The statistical significance (nominal P-value) of the ES was 252 
estimated using a gene set-based permutation test. The estimated significance is adjusted 253 
for multiple hypothesis testing by normalising the enrichment score (NES) and then 254 
calculating the false discovery rate (FDR) corresponding to each NES. The GSEA user manual 255 
recommends an FDR cut-off of 25% for significant enrichment of a particular gene set using 256 
the gene set permutation based method. In this study, an FDR cut off value of 0.05 was 257 
used. DAVID was used to identify significant GO (gene ontology) terms and KEGG (Kyoto 258 
encyclopaedia of genes and genomes) pathways in the list of genes that had gene 259 
expression associated with bacteriology score. The EASE test and a multiple testing 260 
correction (Bejamini) were used to identify significantly enriched functions. All genes on the 261 
microarray were used as the background for this analysis.  262 
cDNA synthesis 263 
 10 
 
Two µg of each endometrial RNA sample (final volume = 40 µL) were used for cDNA 264 
synthesis using the Invitrogen Superscript III Supermix kit (Invitrogen Corporation, Carlsbad, 265 
CA).  Total RNA was transcribed according to the manufacturer’s instructions using 27µM of 266 
random pentadecamers. Briefly, RNA and random primers were mixed and denatured at 267 
65°C for 5 minutes, followed by 1 minute on ice. Annealing buffer and Superscript/RNase 268 
was added to samples and incubated for 10 minutes at 25°C (primer annealing), followed by 269 
50 minutes at 50°C and 5 minutes at 85°C to inactivate the enzyme. Reverse transcription 270 
controls were performed, whereby the above process was completed without the addition 271 
of superscript enzyme.  272 
Quantitative Real Time PCR 273 
Real time PCR using the Roche Lightcycler 480 was performed using the Roche real time PCR 274 
master mix (Lightcycler 480 Probes Master) in combination with Roche Universal Probe 275 
Library (UPL) assays (Roche diagnostics, Indianapolis, IN, USA). Assays were designed using 276 
Roche UPL design software. All assays were designed to span an intron-exon boundary.  277 
The PCR reaction volume was 10 µL, consisting of 0.5 µM of each primer and 0.1 µM of 278 
probe. Standard cycling conditions were used [95°C for 10 minutes, (95°C for 10 seconds, 279 
60°C for 30 seconds) x 50 cycles, 40°C for 40 seconds].  280 
Each PCR experiment included a reaction in which template was replaced by water, and a 281 
reaction omitting reverse transcriptase as controls. Triplicate measurements were 282 
performed for all samples and standard curves. The percent coefficient of variation (%CV) 283 
for Cps was calculated for each sample. All samples for each gene were run on the same 284 
plate.  285 
Endogenous control genes 286 
The Roche Lightcycler 480 software (Roche diagnostics, Indianapolis, IN, USA) was used to 287 
perform ‘absolute quantification’ analysis of endogenous control gene expression using the 288 
standard curve second derivative maximum analysis method, which is a non-linear 289 
regression line method. A six point standard curve was used with a starting dilution of 1 and 290 
final concentration of 1.6E-03. 291 
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Five endogenous control genes (AP3D1, C11H9ORF78, RPS9, RPS15A and PPIA) were tested 292 
across all samples and their suitability determined using NormFinder and GeNorm (4, 64). 293 
Two novel endogenous control genes (AP3D1 and C11H9ORF78) were derived from the 294 
microarray data as described previously (66). These two genes were the most stably 295 
expressed genes identified using microarray analysis. GeNorm identified RPS9 and RPS15A 296 
as the best two genes for normalization (0.286 and 0.297 M values respectively with a 297 
combined average expression stability value of < 0.2). The next best gene was AP3D1 with 298 
an M value of 0.263. Normfinder identified RPS9 and AP3D1 as the best combination of 299 
genes (0.008 and 0.009 stability values, respectively, with a combined stability value of 300 
0.008). The next best gene was RPS15A with a stability value of 0.013. Based on these 301 
results the best 3 genes (AP3D1, RPS9 and RPS15A) identified by both programmes were 302 
used for normalisation.  303 
Relative quantification  304 
The Roche Lightcycler 480 Software (Roche diagnostics, Indianapolis, IN, USA) was used to 305 
perform quantification using the ‘advanced relative quantification analysis algorithm’.  306 
Three endogenous control genes (AP3D1, RPS9 and RPS15A) were used to normalize the 307 
data, taking the geometric mean of the normalized ratio of target gene to each reference 308 
gene. A calibrator sample was then used as a control, whereby each calculated expression 309 
value was normalized to the calibrator sample. 310 
The RT-PCR results were compared to those obtained using the microarray for four 311 
differentially expressed genes (CCL2, GAPDH, IL8, MMP1, MSTN, PGST1, and TIMP1). 312 
Correlation coefficients were calculated for all genes to compare the calculated gene 313 
expression data from qRT-PCR and the microarray data. Genes for RT-PCR were selected 314 
based on two criteria: biological significance and fold change (Table 1).   315 
DNA methylation 316 
DNA extraction and quality control 317 
DNA was extracted from endometrial tissue using a Qiagen DNAeasy blood and tissue kit 318 
(QIAGEN catalogue# 69506). DNA quantity was determined by spectrophotometry using a 319 
Nanodrop ND-1000 (Nanodrop Technologies, Wilmington, DE). Genomic DNA integrity was 320 
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assessed by running it on a 0.8% Agarose Gel. Genomic DNA purity was assessed by the 321 
NanoDrop® ND-1000 UV-Vis Spectrophotometer (Nanodrop technologies, Rockland, USA). 322 
DNA was considered to be good quality when there was a single clear band when run 323 
against a reference genomic DNA sample. 324 
Sonication and immunoprecipitation of methylated regions 325 
DNA was sonicated and immunoprecipitated as described previously  (65). Briefly, 5 µg of 326 
DNA was sonicated, and the efficiency of sonication tested on the Agilent Bioanalyser. An 327 
ideal smear size ranged between 100-700 bp. The sonicated DNA was then 328 
immunoprecipitated using Anti 5 methyl cytidine (Cat. no: Eurogentec Ref: MECY_0500) 329 
bound to Pan Mouse IgG Dynabeads (Invitrogen Cat no: 110.41). DNA was eluted in 1% SDS 330 
solution at 65°C. Input DNA (whole cell extract- genomic DNA) and IP DNA were precipitated 331 
with 3M Acetate after a Phenol:chloroform (25:24:1) clean up, using heavy phase lock gels 332 
Cat. No. Eppendorf (ref # 2302830). 333 
Labeling and microarray hybridization 334 
A 400K custom designed Agilent microarray (2 x 400K array format, AMADID, Part no. and 335 
GEO platform are 027994, G4820A and GPL16270 respectively) was used for microarray 336 
hybridization. Microarray design has been described previously (65). Briefly, probes were 337 
designed to target all CpG islands in the bovine genome as designated by the UCSC genome 338 
browser (bosTau4.0). Input DNA was labeled with Cy3 and IP DNA with Cy5 fluorescent dye, 339 
using Agilent's Genomic DNA labeling kit (Cat. no. 5190-0453). Labeled samples were 340 
cleaned and concentrated using Microcon YM-30 columns (Millipore Cat. no. 42410). All of 341 
the labeled IP DNA (~ 3-4 µg) and 4 µg of labeled input DNA were used for microarray 342 
hybridization. Microarrays were hybridized for 40 hours at 65°C and then washed using a 343 
CGH wash buffer 1 and 2 for 5 minutes and 1 minute, respectively. 344 
Microarray Scanning and Data Analysis 345 
Microarray scanning and data analysis were conducted as described previously (65). Briefly, 346 
hybridized arrays were scanned at 2 μm resolution on an Agilent Technologies Scanner 347 
G2505C. Agilent Feature Extraction software (v10.5.1.1) was used for image data extraction 348 
and Agilent Genomic Workbench software was used for analysis. The centralization method 349 
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was used to normalize the data and methylation states were obtained using the BATMAN 350 
algorithm. The BATMAN algorithm determines the absolute methylation level for CpG 351 
dinucleotides contained within DNA fragments queried by probes across the microarray.  352 
The methylation detection algorithm normalizes the log-ratios for each probe, based on its 353 
melting temperature, and returns the methylation status of a probe. Z-Scores and P-values 354 
were derived from the Gaussian data to give probabilities and confidence values for 355 
methylated and unmethylated probe populations. The algorithm then calculates a 356 
methylation log Odds, which gives the relative probability that a probe is more likely 357 
methylated than unmethylated.  358 
Mapping of microarray probes to genes 359 
Genomic co-ordinates for methylation probes were queried against RefSeq genes in the 360 
bovine genome (refFLAT file from UCSC bosTau4.0 (https://genome.ucsc.edu/)). Probes that 361 
mapped within the transcriptional boundaries or 10kb 5’ of the transcriptional start site of a 362 
gene were annotated to that gene. Annotated methylation probes were then mapped to 363 
gene expression probes using the RefSeq accession as a common identifier.  364 
Correlation between DNA methylation and gene expression 365 
Correlations between DNA methylation and gene expression data for mapped probes were 366 
obtained using linear models, including infection status and tissue, and interactions in the 367 
model, giving a within group correlation between the 2 measurement types.  A Benjamini 368 
Hochberg adjustment was made on the significance levels for the correlations. 369 
The top 1,000 correlated genes were then compared to the lists of differentially expressed 370 
genes and enriched pathways. Methylation data have been submitted to NCBI gene 371 
expression omnibus (GSE60831). 372 
Results 373 
Milk production and metabolites 374 
There were no differences detected in any of the milk production parameters measured or 375 
in the metabolites measured in this study (Table 1). 376 
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Progesterone and bacteriology 377 
There were no differences in the bacteriology scores or concentration of progesterone in 378 
SCE and CON cows. Mean progesterone for CON and SCE cows was 1.4ng/mL and 3.4ng/mL 379 
respectively (SED 2.1, P = 0.4). The mean bacteriology scores for CON and SCE cows were 2.2 380 
and 4.2 respectively (SED 1.6. P = 0.2). Four cows had an active corpus luteum, as evidence 381 
by progesterone concentrations above 1 ng/mL (3 SCE and 1 CON cow).   382 
Histology 383 
There was no significant difference (P > 0.05) between CON and SCE cows for any of the 384 
immune cells counted except for lymphocytes in the stratus spongiosum and stratus 385 
compactum (P < 0.05), where there were greater numbers in the SCE cows (Table 3). The 386 
number of neutrophils present in the uterus of CON and SCE cows did not differ in the 387 
epithelium (P = 0.18) or the stratum compactum (P = 0.45. Regression analysis revealed a 388 
positive linear (P = 0.001) association between bacteriology score and stratum compactum 389 
neutrophil numbers and a negative association (P < 0.02) between bacteriology score and 390 
epithelial lymphocyte and macrophage numbers. There was also a non-linear association 391 
among bacteriology score and epithelial neutrophils (P < 0.0001), stratum spongiosum 392 
lymphocytic foci (P = 0.003) and stratum spongiosum plasma cells (P < 0.0001) which were 393 
all greater with increased bacteriology score (Table 3).  394 
Gene expression 395 
For analysis of differential gene expression, cows with greater than 1 ng/mL of plasma 396 
progesterone were considered to have a functional corpus luteum and were omitted from 397 
the analysis. Three SCE and one CON cow were excluded based on this criterion. These 398 
samples were excluded because progesterone can markedly affect the immune response 399 
(29, 49). Analyses revealed 1,856 probes to be differentially expressed in cows with (SCE) 400 
versus without (CON) uterine inflammation (P < 0.05, Storey Multiple testing correction, 401 
supplementary Table 1). In addition, linear regression analysis revealed 2,976 probes that 402 
had significant correlations between gene expression and bacteriology score 403 
(Supplementary Table 1). Correlation of qRT-PCR and microarray data was 0.86 on average 404 
with all correlations above 0.7 for all genes tested (Table 1). 405 
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Pathway Analysis 406 
Comparison of SCE and CON cows 407 
Analysis of differentially expressed genes using GSEA identified several enriched pathways in 408 
the SCE animals compared with the CON animals, the majority of which were related to the 409 
innate and adaptive immune response pathways in the caruncular endometrium (Table 4 410 
and 5). There were no pathways enriched in the CON group. Several of the genes in the 411 
enriched pathways displayed large expression differences between the two groups while 412 
the enriched pathways in the intercaruncular endometrium showed relatively small 413 
differences (data not presented) in gene expression between the two groups (Table 5).  414 
Gene expression associations with bacteriology score 415 
DAVID analysis revealed several pathways enriched in genes with a significant association 416 
among gene expression and bacteriology score (Table 6). The majority of pathways were 417 
related to both the innate and adaptive immune response. Gene ontology analysis using 418 
DAVID revealed several biological processes that were enriched in the genes that had 419 
expression data correlated to the bacteriology score (Table 7). The top three gene ontology 420 
terms were defense response, inflammatory response and the innate immune response 421 
(Tables 6 and 7).  422 
Correlation of DNA methylation and gene expression data 423 
Transcription data from RNA extracted from the same tissues that DNA was extracted from 424 
for this study were used to identify genes potentially regulated by DNA methylation. No 425 
correlations were significant after correction for multiple hypothesis testing (P < 0.05). 426 
Therefore, the 1,000 most statistically significant data points were used for subsequent 427 
analysis (688 were unique genes).  Forty five percent of these DNA methylation probes were 428 
negatively correlated with the signal from gene expression probes while 55% were positively 429 
correlated. When this gene list was compared with gene expression in the same tissue, 13% 430 
of these were differentially expressed between SCE and CON animals and 10% 431 
demonstrated positive correlations with bacteriology score (Supplementary Table 2). The 432 
microarray data have been submitted to the NCBI gene expression omnibus (GSE58794). 433 
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Discussion  434 
Genes of the innate immune system were upregulated in cows with sub-clinical 435 
endometritis and their expression was positively correlated with bacteriology score. Several 436 
pathways involved in the innate immune response were enriched in SCE cows and there was 437 
significant enrichment for inflammatory and immune response pathways and GO terms in 438 
genes demonstrating a significant correlation among bacteriology score and gene 439 
expression. Consistent with activation of toll like receptors (TLR) by microorganisms present 440 
in the uterus, there was enrichment for the TLR signaling pathway, including increased 441 
expression of the transcription factor NFKB1, the pro-inflammatory cytokines IL1A and IL1B 442 
and downstream chemokines, cytokines, and acute phase and antimicrobial proteins in the 443 
endometrium of SCE cows. The endometrium expresses high levels of pattern recognition 444 
receptors (PRR), such as TLR, which recognize pathogen-associated molecular patterns 445 
(PAMPS) present on microorganisms (1, 26). Binding of those PRR to PAMP initiates host 446 
defense mechanisms, such as production of inflammatory cytokines and chemokines (26, 447 
41). These, in turn, promote recruitment of immune cells to the site of infection, production 448 
of acute phase and antimicrobial proteins, and activation of the adaptive immune system (2, 449 
3) in cows with sub-clinical endometritis. It is well established that sub-clinical endometritis 450 
(defined by elevated PMN) during the postpartum period is associated with poor 451 
reproductive performance (27, 39, 40). Gene expression profiles in cows with subclinical 452 
endometritis in this study indicate that the immune response is activated, potentially 453 
resulting in a local pro-inflammatory environment in the uterus. If this period of 454 
inflammation is prolonged, it could result in tissue damage or failure to complete involution 455 
of the uterus and this may create a sub-optimal environment for future pregnancy. 456 
Inflammation in the uterus during embryo development could result in failure to create 457 
immune tolerance to the embryo and therefore pregnancy may be lost due to immune 458 
rejection of the embryo. 459 
Antimicrobial proteins and the acute phase response  460 
During parturition the anatomical defense barriers of the uterus are compromised, making 461 
it vulnerable to infection from microorganisms (5, 43, 59). Bacterial invasion of the uterus 462 
triggers local immune responses including expression of pro-inflammatory cytokines that 463 
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trigger epithelial and recruited innate immune cells to produce antimicrobial peptides 464 
(AMP) and acute phase proteins (12). Consistent with this, several antimicrobial peptides 465 
(LAP, TAP, DEFB1, DEFB10, DEFB103B, DEFB7) and acute phase proteins (APP), including 466 
SAA3, LBP and the complement gene CFB, had greater gene expression in SCE cows. 467 
Furthermore, the expression of several complement genes (CFB, C1QA, C1R, C1S and C2) 468 
was positively correlated with bacteriology score. Additionally, gene expression of the S100 469 
family of calcium binding proteins that possess antimicrobial properties and are a marker of 470 
inflammation, were upregulated in the endometrium of SCE cows (S100A12, S100A14, 471 
S100A3, S100A4, S100A8, S100A9). Antimicrobial proteins are an important part of mucosal 472 
immunity and, along with mucins, they prevent attachment and colonization of the uterus 473 
with microorganisms (13). Several of these molecules act as opsonins for macrophages and 474 
neutrophils, enhancing phagocytosis efficiency (31). The APP LBP binds to the bacterial 475 
endotoxin, lipopolysaccharide (LPS) and presents it to membrane bound CD14. This complex 476 
can then interact with TLR4, triggering a pro-inflammatory reaction (69). Furthermore, the 477 
APP SAA enhances neutrophil respiratory burst and macrophage TNF-α and IL-10 production 478 
(57). Additionally, SAA binds to high density lipoprotein (HDL), becoming the major 479 
apolipoprotein of HDL. This results in reduced reverse cholesterol transport. During the 480 
acute phase response, when there is an increase in SAA, secretory phospholipase also 481 
increases. This phospholipase can hydrolyse surface phospholipids on HDL increasing 482 
delivery of cholesterol to peripheral tissues for cellular repair (48). The availability of 483 
lipoproteins during early lactation is limited by the ability of the liver to assemble and 484 
release them (28, 38, 56). Limited availability of lipoproteins for tissue repair could have 485 
negative consequences for uterine recovery postpartum. In addition, lipoproteins can bind 486 
endotoxin from bacteria, competing with immune cells for endotoxin binding (30). Binding 487 
of endotoxin by HDL and delivery to the liver for breakdown could be an important 488 
mechanism to both clear infection and limit the pro-inflammatory reaction to infection.  489 
Up-regulation in the genes of acute phase and antimicrobial proteins in SCE cows, despite 490 
no difference in the bacteriology score, may be due to inappropriate continuation of a pro-491 
inflammatory response to cleared bacteria. Alternatively, given the culture dependent 492 
measurements undertaken in this study, there could be undetected differences in uterine 493 
microbial diversity underlying the etiology of sub-clinical endometritis. In support of this, 494 
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studies utilizing culture-independent methods have reported that the microbiome of cows 495 
with endometritis or metritis differs to that of healthy cows, particularly at days 34-36 496 
postpartum (55). Furthermore, cows with a greater prevalence of particular bacteria at day 497 
35 postpartum were less likely to be pregnant by day 200 postpartum (36).  Expression of 498 
acute phase and antimicrobial genes in the absence of bacteriology differences may be 499 
indicative of a failure to control the pro-inflammatory state in some cows; however, further 500 
investigation of the microbiome of the post-partum uterus is warranted.   501 
Recruitment of innate immune cells 502 
Cows with sub-clinical endometritis were actively recruiting immune cells to the uterus 503 
through the expression of chemotactic genes. The chemokine signaling pathway was 504 
enriched in SCE cows and there was enrichment for the chemokine signaling pathway in 505 
genes correlated with bacteriology score.  Increased expression of IL-8 and CXCL6, 506 
chemotactic factors for recruitment of neutrophils, along with the immune cell surface 507 
marker PTPRC in SCE cows, is consistent with the diagnosis of sub-clinical endometritis (17, 508 
62). Furthermore, IL-1B expression stimulates expression of both CXCL6 and IL-8 (54) and 509 
was upregulated in SCE cows and positively correlated with bacterial load. There was also a 510 
positive correlation among bacteriology score and gene expression of IL-8 and CXCL6, 511 
indicating that with increased bacterial load, the uterus attempts to recruit more 512 
neutrophils to resolve the infection. Further, histological analysis revealed a positive 513 
association among bacteriology score and tissue neutrophil number, as well as a trend for 514 
increased neutrophils in SCE cows. Additionally, there was an increase in CD14 expression 515 
associated with bacteriology score which suggests along with increased bacterial load that 516 
there may have been an increase in the recruitment of other immune cell types, such as 517 
monocytes to the uterus (46). Consistent with this, there was upregulation of monocyte 518 
chemoattractants. The chemokine CCL2 is a strong chemoattractant for monocytes and 519 
CXCL6 attracts both monocytes and neutrophils (19). Both of these genes were upregulated 520 
in SCE cows, with CXCL6 expression positively correlated with bacterial load. Once 521 
monocytes reach the site of infection, they differentiate into tissue macrophages or 522 
dendritic cells (20, 61). Therefore, it might be expected that there would be greater 523 
numbers of tissue macrophages with increased bacteriology score. However, there was a 524 
negative linear trend for macrophage number with increased bacteriology score.  Lack of 525 
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macrophage numbers despite upregulation of monocyte chemoattractants may indicate 526 
monocytes were unresponsive to signals and could explain why some cows have a 527 
prolonged inflammatory state. Alternatively, with the presence of more macrophages there 528 
should be greater efficiency in clearing pathogens. 529 
Natural killer cells (NK cells) may be activated in the uterus of SCE cows and there was a 530 
positive association between NK cell pathway gene expression and bacteriology score. The 531 
NK cell mediated cytotoxicity pathway was enriched in SCE cows and in genes correlated 532 
with bacteriology score. Furthermore, histological assessment of the uterus revealed 533 
greater lymphocytes in the stratum compactum of SCE cows, which may be indicative of NK 534 
cell enrichment. There was upregulation of the CD16- NK cell chemoattractant and co-535 
stimulator of proliferation CCL19 in the uterus of SCE cows and the CD16+ chemoattractant 536 
IL-8 (46, 48). Genes in the NK cell mediated cytotoxicity pathway that were upregulated in 537 
SCE cows include the NK cell activating receptors (FCGR3A and NCR3), along with genes 538 
encoding cytotoxic granules (PRF1 and GZMB), and intracellular signaling proteins (FCER1G, 539 
ZAP70, syk, and VAV-1) required for the release of those cytotoxic granules (8). NK cells link 540 
the innate and adaptive immune response and can be both disease controlling or 541 
promoting, depending on the subset and activation state (70).  Further research 542 
investigating the types of NK cells present in the uterus of cattle is required to unravel their 543 
potential role in subclinical endometritis. 544 
Adaptive immune response 545 
The adaptive immune response is activated in cows that fail to eliminate pathogens 546 
effectively via the innate immune response. The hypothesis that the adaptive immune 547 
response is active in SCE cows and in cows with a high bacteriology score is supported by 548 
pathway analysis. Several pathways of the adaptive immune response were enriched in SCE 549 
cows and were enriched in genes that had a positive correlation with bacteriology score. 550 
Furthermore, there were greater numbers of lymphocytes in SCE cows, and lymphocytic foci 551 
and plasma cell numbers were positively associated with bacteriology score. In early 552 
lactation, dairy cattle are prone to metabolic stress associated with negative energy 553 
balance. During this period, the immune system is suppressed; for example, there is 554 
evidence that neutrophil function is impaired (18, 23, 37). Impaired function of the innate 555 
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immune system would likely result in delayed elimination of pathogens, prolonging infection 556 
and, consequently, a harmful inflammatory state. While the innate immune system is the 557 
first line of defense against pathogens, a co-ordinated response from both the innate and 558 
adaptive immune system is required for efficient elimination of pathogens. Cows 559 
experiencing a period of severe negative energy balance at 2 weeks postpartum had more 560 
stromal lymphocytic foci (63). While we could not determine if higher bacteriology score 561 
was the result of inefficiency in the innate or adaptive immune system, without an efficient 562 
innate immune response to contain infection there would be a higher likelihood of adaptive 563 
immune response activation, and prolonged inflammation.  564 
DNA methylation  565 
There was no significant correlation among DNA methylation and gene expression. To 566 
identify genes for future study, the 1,000 most significant correlations were compared with 567 
genes in the most enriched pathways.  There were very few genes that were in both the top 568 
1,000 correlations and in the most significantly enriched pathways. Furthermore, very few 569 
genes that were differentially expressed between SCE and CON cows or those that were 570 
correlated with bacteriology score were in the top 1,000 correlations for DNA methylation. 571 
Interestingly, most of these genes were positively correlated with DNA methylation rather 572 
than negatively correlated. Of particular interest is the positive correlation among SAA3 573 
gene expression and promoter DNA methylation. This gene is up-regulated in response to 574 
infection, in agreement with the current study; however, treatment with a DNA methylation 575 
inhibitor results in greater expression of SAA3 in response to LPS (22), suggesting that DNA 576 
methylation in the promoter of SAA3 may result in decreased responsiveness to infection. 577 
The innate immune response to infection is regulated by DNA methylation and histone 578 
acetylation (53) and variation in DNA methylation could explain differing responses to post-579 
partum infection in dairy cows (22). Further, loss of epigenetic marks, such as acetylation of 580 
histone tails that enable transcriptional activation of pro-inflammatory genes, has been 581 
proposed as a mechanism to prevent excessive inflammation (15). Removal of acetyl tags 582 
from histone tails results in suppression of gene expression; treatment of cells with histone 583 
deacetylase inhibitors (maintaining acetyl tags on histones) results in increased NFKB1 584 
stimulated expression of inflammatory genes. While there was a lack of detectable 585 
association between DNA methylation and gene expression in this study, there are several 586 
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studies using a similar genome-wide approach that provide compelling evidence supporting 587 
the role of DNA methylation in regulating endometrial function. For example, in women 588 
there is evidence for reproductive cycle stage dependent DNA methylation associated with 589 
transcription (25). Genome-wide DNA methylation is altered in women with endometriosis 590 
(14, 44). Furthermore, in the cow, DNA methylation is negatively correlated with gene 591 
expression in the endometrium during pregnancy (65).  DNA methylation is very cell specific 592 
(16, 24) and given that the samples used in this study were from a biopsy sample it is likely 593 
that true correlations among DNA methylation and gene expression were not detected 594 
because of the ‘noise’ created by the many different cell types present. Future research 595 
should focus on developing techniques for isolation of specific cell types from biopsy 596 
samples such as laser capture microdissection. DNA methylation is one of the mechanisms 597 
used by cells to create unique expression profiles and functions among different types of 598 
cells. Therefore, establishing which cell types express key genes and how DNA methylation 599 
patterns drive these changes in a single cell type will improve our understanding of the 600 
biology of post-partum uterine infection. 601 
Conclusion 602 
We hypothesized that aberrant DNA methylation may be involved in the sub-fertility 603 
associated with post-partum uterine inflammation. While we were unable to detect any 604 
association among gene expression and DNA methylation we did find that the expression of 605 
genes regulating the immune response were greater in cows with sub-clinical endometritis. 606 
The lack of differences detected in bacteria present in the uterus suggests that some cows 607 
may fail to control inflammation even when there are no bacteria present. Further, lack of 608 
difference in macrophage number in the uterus despite greater expression of macrophage 609 
attracting chemokines suggests that these cells may become unresponsive to these signals, 610 
delaying tissue repair and prolonging inflammation. If this inflammation is sustained into the 611 
breeding period it could result in a sub-optimal environment for embryo development and 612 
potentially failure to create local immune tolerance to the embryo.  613 
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Table Legends 840 
Table 1 qRT-PCR confirmation of microarray. Primer sequences and UPL probe used for 841 
qRT-PCR assays. 842 
Table 2  Milk production and metabolite data 843 
ANOVA was used to determine the effect of health status (SCE vs CON) on measurements of 844 
milk production and metabolites. Data is presented at Least square means (LSMeans). 845 
Table 3 Histological assessment of uterine tissues. Results for the analysis of immune cells 846 
present in the uterine sample. ANOVA, linear regression and quadratic regression were used 847 
to determine the effects of health status (SCE vs CON) and bacteriology score, on the 848 
number of immune cells present in the epithelia, stratus compactus, and stratus 849 
spongiosum. Immune cells detected included, lymphocytes, neutrophils, eosinophils, 850 
macrophage, and plasma cells. The presence of lymphocytic foci was also assessed.  851 
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Table 4 Enriched pathways identified using GSEA for the comparison of SCE and CON cows 852 
in caruncular (CAR) and intercaruncular (ICAR) endometrium. Enrichment score (ES), 853 
normalised enrichment score (NES), false discovery rate (FDR), family wise error rate 854 
(FWER). 855 
Table 5 Genes in the enriched pathways identified using GSEA for the comparison of SCE 856 
and CON cows in caruncular (CAR) endometrium. Enrichment score (ES), normalised 857 
enrichment score (NES), false discovery rate (FDR), family wise error rate (FWER). Genes 858 
(human gene symbols) with fold changes greater than 1.5 or less than -1.5 are in bold. 859 
Table 6 Pathways identified as enriched using DAVID for genes that have expression 860 
associated with bacteriology score. The number of genes in the pathway (count), 861 
Percentage of the genes in the pathway (%), total number of genes in the list (LT), number 862 
of genes in the background list in the pathway (PH), number of genes in the background list 863 
in any ontology term. The ratio of the percentage of genes in the pathway to the percentage 864 
of genes in the background that are in that pathway (fold enrichment). 865 
Table 7 Enriched GO Terms identified using DAVID in genes that have expression 866 
associated with bacteriology score. The number of genes in the term (count), Percentage of 867 
the genes in the term (%), total number of genes in the list (LT), number of genes in the 868 
background list in the term (PH), number of genes in the background list in any ontology 869 
term. The ratio of the percentage of genes in the term to the percentage of genes in the 870 
background that are in that term (fold enrichment) 871 
Supplementary Table 1 872 
Gene expression analyses revealed 1,856 probes to be differentially expressed in cows with 873 
or without uterine inflammation (q<0.05, Storey multiple testing correction).  Additionally, 874 
2,976 probes had gene expression correlated with bacteriology score (P<0.05, Benjamini-875 
Hochberg multiple testing correction). The coefficient of determination (r2) describes the 876 
proportion of the variance in gene expression that is predicted from the bacteriology data. 877 
Supplementary Table 2 878 
DNA methylation correlations with gene expression. As there were no significant differences 879 
detected after multiple hypothesis testing, the 1,000 most significant correlations are 880 
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presented. Forty five percent of these DNA methylation probes were negatively correlated 881 
with signal from gene expression probes while 55% were positively correlated. When this 882 
gene list was compared with gene expression on the same tissue, 13% of these were 883 
differentially expressed between SCE and CON animals and 10% demonstrated positive 884 
correlations with bacteriology score. 885 
Table 1
Forward Reverse Probe Exon boundary Correlation P-value
CCL2 CCAGCAGCAAGTGTCCTAAA GCTTGGGGTCTGCACATAAC 61 Exon2/3 0.8 0.04
GAPDH GAAGCTCGTCATCAATGGAAA CCACTTGATGTTGGCAGGAT 9 Exon2/3 0.9 0.04
IL8 CTGGCTGTTGCTCTCTTGG CTGTACTCATTCTTGACAGAACTGC 15 Exon1/2 0.8 0.04
MMP1 TGGGAAAACCTATTTCTTTGTTG CCTGCATCCATGGACTGTTTA 67 Exon7/8 0.7 0.04
MSTN TCTTGCTGTAACCTTCCCAGA TTGGTGTGTCTGTTACCTTGACTT 2 Exon2/3 0.8 0.04
PGST2 CCCTATGAATCATTTGAGGAACTT TGTCTCCATAGAGCGCTTCTAACT 46 Exon8/9/10 0.8 0.05
TIMP1 TATGCTGCTGGTTGTGAGGA CTCTGGAACCCCTTGTCAGA 100 Exon4/5 0.7 0.15
Reference genes
AP3D1 AGTGCTCATCTCCCTGTCATC CCTCAATTTCTGAACGCAGAG 89 Exon8/9/10/11
C11H9ORF78 CATTTTCCGCAGAAACCAAC CCGCTTCTTCAGTTCTGTCTC 153 Exon4/5
RPS15A TCAGCCCTAGATTTGATGTGC GCCAGCTGAGGTTGTCAGTA 32 Exon4/5
PPIA GTCAACCCCACCGTGTTCT TTCTGCTGTCTTTGGAACTTTG 152 Exon1/2/3
RPS9 TGAGGATTTCTTGGAGAGACG ATGTTCACCACCTGCTTGC 138 Exon4/5
Primer Sequences 3' to 5'
Table 2
Parameter CON SCE SED P-Value
Total Protein (g/L) 77.17 82.17 3.96 0.24
Albumin (g/L) 37.50 36.83 2.05 0.75
Globulin (g/L)1 39.67 45.33 3.19 0.11
Albumin:Globulin ratio 0.95 0.83 0.09 0.23
Magnesium (mmol/L) 0.70 0.67 0.09 0.70
Non-esterified fatty acids (mmol/L) 1.70 1.50 0.26 0.46
GDH (IU/L)2 28.33 24.33 7.85 0.62
ASAT (IU/L)3 87.50 78.50 6.61 0.20
Milk yield (kg/d)4 23.51 22.91 1.74 0.74
Milk Fat (%)5 4.35 4.40 0.31 0.90
Milk crude protein (%)5 3.48 3.59 0.09 0.22
Total solids (%)5 7.83 7.99 0.36 0.68
Somatic cell count*5 45.69 47.33 12.60 0.60
Live weight (kg)6 477.39 494.56 26.08 0.53
Average body condition (units)6 4.36 4.28 0.22 0.71
1 Globulin is calculated when albumin is subtracted from total protein
2 GDH = glutamate dehydrogenase
3 ASAT = aspartate aminotransferase
4LSMean of daily measures taken over 26 to 31 days (varies across cows)
5 LSMean of measures taken at weekly herd tests (range from 3 to 4 herd tests
per cow)
6 LSMean of 3 measurements taken post-calving at weeks 1, 2 and 3
* P-Values are based on analysis of Log10 transformed data
Table 3
Location Cell type CON SCE SEM SED P-value Intercept Bacteriology P-Value Intercept Bacteriology Bacteriology2 Probability P-Value
Neutrophil 2.03 7.17 2.50 3.54 0.18 -1.88 2.05 <0.0001 1.29 -0.67 0.32 0.01 <0.0001
Lymphocyte 10.51 11.26 2.83 4.00 0.86 15.96 -1.60 0.02 17.68 -3.08 0.17 0.46 0.05
Macrophage 0.33 0.02 0.17 0.24 0.22 0.28 -0.03 0.49 0.29 -0.04 0.00 0.99 0.80
Eosinophil 0.00 0.00 0.00 0.00 0.34 0.00 0.00 0.52 0.00 0.00 0.00 0.27 0.46
Neutrophil 12.19 24.07 10.66 15.08 0.45 -5.84 7.57 <0.001 -2.25 4.49 0.36 0.61 0.01
Lymphocyte 49.81 79.96 9.63 13.62 0.05 61.16 1.18 0.71 72.12 -8.21 1.09 0.40 0.65
Macrophage 12.27 10.40 3.09 4.37 0.68 16.07 -1.50 0.05 14.80 -0.41 -0.13 0.66 0.15
Eosinophil 1.69 0.27 1.14 1.61 0.40 0.42 0.18 0.58 -0.94 1.34 -0.14 0.30 0.48
Plasma cells 2.17 79.70 31.65 44.76 0.11 -35.03 23.99 <0.005 32.18 -33.57 6.70 <0.001 <0.001
Lymphocytic 




foci 0.28 3.67 1.04 1.47 0.04 0.00 0.62 0.05 2.66 -1.66 0.27 0.01 <0.005





KEGG pathway ES NES FDR FWER
Primary immunodeficiency 0.66 2.20 <0.01 <0.01
Natural killer cell mediated cytotoxicity 0.51 2.15 <0.01 <0.01
Proteasome 0.58 2.13 <0.01 <0.01
Systemic lupus erythematosus 0.53 2.07 <0.01 <0.01
Amino sugar and nucleotide sugar metabolism 0.55 2.06 <0.01 0.01
RNA polymerase 0.63 2.02 <0.01 0.01
Chemokine signaling pathway 0.44 2.03 <0.01 0.01
T cell receptor signaling pathway 0.48 2.04 <0.01 0.01
Intestinal immune network for IGA production 0.61 1.99 <0.01 0.02
Parkinsons disease 0.43 1.95 <0.01 0.03
Citrate cycle tca cycle 0.58 1.93 <0.01 0.04
Spliceosome 0.43 1.91 0.01 0.05
Cytosolic dna sensing pathway 0.53 1.90 0.01 0.06
Pyrimidine metabolism 0.45 1.88 0.01 0.07
Oxidative phosphorylation 0.42 1.87 0.01 0.09
B cell receptor signaling pathway 0.46 1.83 0.01 0.13
Alzheimers disease 0.39 1.82 0.01 0.15
Autoimmune thyroid disease 0.61 1.81 0.01 0.17
Purine metabolism 0.39 1.79 0.01 0.19
Glycosphingolipid biosynthesis lacto and neolacto series 0.62 1.76 0.02 0.25
N glycan biosynthesis 0.49 1.75 0.02 0.28
Huntingtons disease 0.37 1.75 0.02 0.28
Graft versus host disease 0.60 1.74 0.02 0.31
Prion diseases 0.53 1.72 0.02 0.34
Fc epsilon ri signaling pathway 0.43 1.67 0.03 0.48
Nod like receptor signaling pathway 0.44 1.67 0.03 0.50
Glycolysis gluconeogenesis 0.45 1.66 0.04 0.54
Protein export 0.52 1.64 0.04 0.59
Cytokine cytokine receptor interaction 0.35 1.63 0.04 0.62
Parkinsons disease 0.59 2.76 <0.01 <0.01
Oxidative phosphorylation 0.57 2.66 <0.01 <0.01
Alzheimers disease 0.53 2.53 <0.01 <0.01
Citrate cycle tca cycle 0.71 2.38 <0.01 <0.01
Huntingtons disease 0.47 2.29 <0.01 <0.01
Propanoate metabolism 0.65 2.18 <0.01 <0.01
Valine leucine and isoleucine degradation 0.59 2.16 <0.01 0.01
Cardiac muscle contraction 0.56 2.19 <0.01 0.00
Steroid hormone biosynthesis 0.63 2.00 <0.01 0.02
Fatty acid metabolism 0.55 1.97 <0.01 0.03
Glycine serine and threonine metabolism 0.61 1.97 <0.01 0.03
Protein export 0.60 1.94 0.01 0.05
Pyruvate metabolism 0.54 1.89 0.01 0.08
Proteasome 0.48 1.85 0.01 0.11
N glycan biosynthesis 0.51 1.84 0.01 0.11
Retinol metabolism 0.56 1.83 0.01 0.13
Glutathione metabolism 0.48 1.78 0.01 0.18
Arginine and proline metabolism 0.46 1.76 0.02 0.21
Cysteine and methionine metabolism 0.51 1.70 0.03 0.33
Biosynthesis of unsaturated fatty acids 0.55 1.66 0.04 0.44
KEGG pathways enriched in SCE CAR
Enriched in SCE ICAR
Table 5
KEGG Pathway ES NES FDR FWER
primary immunodeficiency 0.66 2.20 <0.001 <0.001
Up-regulated genes
ICOS, TNFRSF13B, ZAP70, CD3E, CD79A, LCK, CD3D, TNFRSF13C, CD40, IL7R, TAP1, BLNK, PTPRC, CD8A, BTK, 
RFX5, TAP2, CD4, IKBKG , CD8B, RFX5, TAP2, IL2RG, ADA, IKBKG
Down-regulated genes
RFXANK, RFXAP, UNG
Natural killer cell mediated cytotoxicity 0.51 2.15 <0.001 <0.001
Up-regulated genes
CD48, TNF, GZMB, RAC2, PIK3CG, SH2D1A, HCST, LCK, LAT, ZAP70, PRF1, VAV1, LCP2, KLRK1, CD244, SYK, 
PIK3CD, HLA-A, CD247, ITGAL, PTPN6, FASLG, ITGB2, FAS, PTK2B , IFNAR1, NCR3, MAP2K1, CASP3, GRB2, 
IFNAR2, FYN, NFATC1, FCGR3A, FCER1G, IFNGR2, TYROBP, PIK3CB, SHC1, MAP2K2, NFATC3, NRAS, BID, PTPN11, 
KRAS, ARAF, PPP3CA, RAC1, PPP3R1, IFNGR1, TNFSF10
PRKCA, PPP3CC, SOS2, MAPK3, RAF1, PIK3R1, NFAT5, PPP3CB, PLCG1, PIK3CA, PAK1, VAV3, , RAC3, PIK3R2, 
SHC2, PIK3R3
Proteasome 0.58 2.13 <0.001 <0.001
Up-regulated genes
PSMB9 , PSMB8, PSMD14, PSMA2, PSMD3, PSMD8, PSMA7, PSMB10, PSMA1, PSMB1, PSMD1, PSME2, PSMB6, 
PSMB2, PSMA6, PSMC4, PSMB4, PSMA5, PSMA4, PSMB3, PSMD6, POMP, , PSMC5, PSMA3, PSME1, PSMD7, 
PSMC3, PSMB5, PSMC6, PSMB7, PSMD11, PSMD12, PSMC1, SHFM1
PSME4, PSMD4, PSMF1, PSMD13, 
Systemic lupus erythematosus 0.53 2.07 0.001 0.004
Up-regulated genes
C3, CD40, TNF, HIST1H2AH, C2, C1QB, C1QC, C1QA, HIST1H2AG, C4A, HLA-DRA, FCGR1A, HIST1H2BN , CD86, 
HLA-DMB, IL10, ACTN1, SNRPD1, HIST1H2BD, HLA-DOA, FCGR3A, ACTN3, SSB, H2AFZ, ACTN4, SNRPB, SNRPD3, 
C1S, HLA-DMA, HIST2H2AC, H3F3A, H2AFX, H2AFV, TROVE2, HIST1H3A, H2AFY
C5, H2AFY2, TRIM21,  ACTN2
Amino sugar and nucleotide sugar metabolism 0.55 2.06 0.001 0.005
Up-regulated genes
NANS, GNPNAT1 , UGDH, GALE, TSTA3, PGM3, PMM2, UXS1, HEXB, GMDS, GFPT2, GMPPA, GFPT1, CMAS, 
CYB5R1, GPI, MPI, GALK2, GALK1, UAP1, UGP2, PMM1, GALT, GNPDA2, NANP, NAGK
GNPDA1, HEXA, PGM1, AMDHD2, CYB5R3, FPGT, GCK, PGM2, FUK, NPL
RNA polymerase 0.63 2.02 0.001 0.009
Up-regulated genes
POLR3G , POLR2L, POLR2E, POLR1B, POLR3D, POLR3K, POLR2C, POLR1C, POLR1A, POLR3B, POLR2K, POLR2F, 
POLR2B, POLR2G, POLR2I, POLR2J, POLR2D, POLR3F
POLR3C
Chemokine signaling pathway 0.44 2.03 0.002 0.009
Up-regulated genes
CXCL5, IL8, CXCL2, CXCR5, CCL19, CCL20, CCR7, CCL2, RAC2, CCL24, PIK3CG, CCL4, CCL8, CCL5, CCL28, LYN, 
CXCR6, ITK, CCR1, RASGRP2, VAV1, CCR5, PRKCB, HCK, PIK3CD, GNG3, GNAI2, CXCL16, PTK2B, ARRB1 , CXCR4, 
PRKCD, STAT3, GNG2, ADRBK1, MAP2K1, CSK, NFKBIB, ADCY7, GRB2, NFKB1, GNG5, GNG10, ROCK2, RAP1A, 
STAT5B, GNB5, GNB2, PRKX, ADCY4, RAP1B, GNAI3, GNB1, IKBKG, PIK3CB, XCL2, SHC1, WASL, RHOA, CXCL10, 
ARRB2, AKT1, NCF1, NRAS, NFKBIA, IKBKB, GNG12, KRAS, CXCL14, RAC1, STAT2, PRKCZ, ROCK1, PRKACB, BCAR1, 
PREX1, FGR, CHUK, PRKACA, GSK3A
RELA, SOS2, JAK2, PLCB3, GNB3, MAPK3, ADRBK2, RAF1, GNGT2, GSK3B, CRK, CCL25, CXCL9, PIK3R1, ADCY3, 
STAT1, GNB4, PIK3CA, FOXO3, GNG7, CCL21, ADCY6, PARD3, GNAI1, PAK1, VAV3, TIAM1, ADCY2, CCL16, PIK3R2, 
CCL14, GNG11ADCY8,  ADCY5, PLCB4, CCL11, CX3CR1, SHC2, PIK3R3
T cell receptor signaling pathway 0.48 2.04 0.002 0.009
Up-regulated genes
ICOS, MAPK13, TNF, CD3D, PRKCQ, CD3G, PIK3CG, PTPRC, ITK, CD3E, LCK, LAT, ZAP70, VAV1, LCP2, PIK3CD, 
CD247, CD8A, CARD11 , CD8B, MAP2K1, IL10, NFKBIB, GRB2, NFKB1, FYN, NFATC1, PDCD1, MALT1, NFKBIE, 
IKBKG, CDK4, NCK1, PIK3CB, MAP2K2, RHOA, NFATC3, AKT1, NRAS, MAPK14, NFKBIA, IKBKB, KRAS, MAP3K7, 
PPP3CA, BCL10, MAPK12, PPP3R1, CHUK, CD4, 
RELA, TEC, PPP3CC, PAK6, SOS2, FOS, MAPK3, CBLB, RAF1, MAPK9, GSK3B, PIK3R1, NFAT5, CBLC, NCK2, PAK4, 
PPP3CB, PDK1, PLCG1, PIK3CA, MAP2K7, PAK1, VAV3, PAK3, PIK3R2,  JUN, PIK3R3
Intestinal immune network for IGA production 0.61 1.99 0.002 0.018
Up-regulated genes
PIGR, ICOS, TNFRSF13C, CD40, CCL28, ITGB7, HLA-DRA , CXCR4, CD86, HLA-DMB, IL10, IL15RA, HLA-DOA, 
MADCAM1, HLA-DMA, TNFSF13, LTBR
CCL25
Parkinsons disease 0.43 1.95 0.003 0.027
Up-regulated genes
UBE2J1, CYCS , SLC25A5, UQCRC1, COX6B2, ATP5B, UBE2G2, CASP3, ATP5G3, NDUFB5, ATP5G1, NDUFA2, 
COX5A, UQCRB, NDUFA4, ATP5C1, UQCRC2, NDUFA5, NDUFS6, NDUFA1, NDUFV1, UQCRQ, COX7B, UBE2L3, 
NDUFB2, VDAC1, NDUFB1, NDUFB8, NDUFS8, SLC25A4, UBE2G1, NDUFS1, COX7A2, CYC1, NDUFB4, UQCR11, 
NDUFC1, UBA1, COX7C, NDUFB9, UQCRFS1, NDUFA10, ND6, NDUFS7, UQCR10, NDUFA9, PARK2, NDUFAB1, 
UBE2J2, NDUFA7, NDUFB7, ATP5J, SDHC, COX5B, NDUFB6, NDUFA4L2, ATP5O, NDUFV2, VDAC3, ATP5F1, 
SEPT5, PPID, NDUFB3, ATP5A1, PARK7, VDAC2, COX7A1, UCHL1, COX6C, NDUFC2
COX4I1, NDUFS4, TH, PINK1, COX4I2, ATP5H, SDHB, COX2, UBE2L6, NDUFA8, NDUFS5, NDUFA3, HTRA2, ATP5D, 
NDUFB10, NDUFS3, UBA7, GPR37, SNCA, NDUFS2, ND2, UQCRH, NDUFA6, COX7A2L, LRRK2, CASP9, ND4L, 
ATP5G2, SLC18A2, ND4, ND5, ATP6,  CYTB, COX3, ND1, SNCAIP
Down-regulated genes















Fc epsilon RI signaling pathway 20 492 48 2862 1.1 1.70E-04 2.4 5.00E-05
Ubiquitin mediated proteolysis 25 492 78 2862 1.4 2.00E-03 1.9 8.50E-04
B cell receptor signaling pathway 20 492 58 2862 1.1 2.60E-03 2 1.00E-03
Neurotrophin signaling pathway 25 492 85 2862 1.4 6.70E-03 1.7 3.30E-03
Focal adhesion 34 492 129 2862 1.9 8.70E-03 1.5 4.90E-03
Adherens junction 16 492 47 2862 0.9 9.30E-03 2 3.70E-03
Complement and coagulation cascades 15 492 43 2862 0.8 9.80E-03 2 3.70E-03
Chemokine signaling pathway 32 492 124 2862 1.8 0.02 1.5 8.70E-03
Regulation of actin cytoskeleton 33 492 130 2862 1.8 0.02 1.5 0.01
NOD-like receptor signaling pathway 13 492 39 2862 0.7 0.03 1.9 0.01
Renal cell carcinoma 15 492 48 2862 0.8 0.03 1.8 0.01
Pathways in cancer 47 492 206 2862 2.6 0.03 1.3 0.02
Methane metabolism 4 492 5 2862 0.2 0.04 4.7 3.70E-03
Pancreatic cancer 14 492 46 2862 0.8 0.04 1.8 0.02
MAPK signaling pathway 39 492 173 2862 2.2 0.06 1.3 0.04
Toll-like receptor signaling pathway 16 492 58 2862 0.9 0.06 1.6 0.03
Colorectal cancer 17 492 63 2862 1 0.06 1.6 0.03
ECM-receptor interaction 13 492 44 2862 0.7 0.06 1.7 0.03
Natural killer cell mediated cytotoxicity 18 492 68 2862 1 0.06 1.5 0.03
Fc gamma R-mediated phagocytosis 17 492 64 2862 1 0.07 1.5 0.04
Arachidonic acid metabolism 10 492 31 2862 0.6 0.07 1.9 0.03
VEGF signaling pathway 14 492 50 2862 0.8 0.07 1.6 0.04
Table 7





Defense response 50 905 133 4828 2.8 4.80E-07 1.80E-07 2
Inflammatory response 31 905 71 4828 1.7 3.40E-06 1.00E-06 2.3
Innate immune response 20 905 37 4828 1.1 7.20E-06 1.50E-06 2.9
Regulation of RNA metabolic process 116 905 432 4828 6.5 1.50E-05 9.10E-06 1.4
Regulation of transcription 157 905 623 4828 8.8 1.70E-05 1.10E-05 1.3
Regulation of transcription, DNA-dependent 112 905 421 4828 6.3 3.30E-05 2.10E-05 1.4
Response to wounding 42 905 120 4828 2.3 3.50E-05 1.50E-05 1.9
Complement activation 9 905 14 4828 0.5 1.50E-03 2.20E-04 3.4
Activation of plasma proteins involved in acute inflammatory response 9 905 14 4828 0.5 1.50E-03 2.20E-04 3.4
Transcription 82 905 323 4828 4.6 2.10E-03 1.40E-03 1.4
Protein maturation by peptide bond cleavage 13 905 28 4828 0.7 2.70E-03 7.40E-04 2.5
Activation of immune response 15 905 35 4828 0.8 2.70E-03 8.40E-04 2.3
Immune response 47 905 169 4828 2.6 3.80E-03 2.20E-03 1.5
Humoral immune response mediated by circulating immunoglobulin 7 905 10 4828 0.4 4.50E-03 5.60E-04 3.7
Complement activation, classical pathway 7 905 10 4828 0.4 4.50E-03 5.60E-04 3.7
Humoral immune response 9 905 16 4828 0.5 4.50E-03 8.90E-04 3
Acute inflammatory response 14 905 33 4828 0.8 4.50E-03 1.40E-03 2.3
Modification-dependent protein catabolic process 39 905 136 4828 2.2 5.00E-03 2.80E-03 1.5
Modification-dependent macromolecule catabolic process 39 905 136 4828 2.2 5.00E-03 2.80E-03 1.5
Adaptive immune response 13 905 30 4828 0.7 5.40E-03 1.60E-03 2.3
Adaptive immune response based on somatic recombination of immune 
receptors built from immunoglobulin superfamily domains 13 905 30 4828 0.7 5.40E-03 1.60E-03 2.3
Cellular macromolecule catabolic process 51 905 191 4828 2.9 6.00E-03 3.70E-03 1.4
Immunoglobulin mediated immune response 11 905 24 4828 0.6 7.80E-03 2.20E-03 2.4
Leukocyte mediated immunity 13 905 32 4828 0.7 9.80E-03 3.30E-03 2.2
B cell mediated immunity 11 905 25 4828 0.6 0.01 3.20E-03 2.3
Respiratory gaseous exchange 5 905 6 4828 0.3 0.01 1.20E-03 4.4
Protein modification by small protein conjugation or removal 15 905 41 4828 0.8 0.01 5.40E-03 2
Protein processing 15 905 41 4828 0.8 0.01 5.40E-03 2
Proteolysis involved in cellular protein catabolic process 41 905 154 4828 2.3 0.02 9.20E-03 1.4
Lymphocyte mediated immunity 12 905 30 4828 0.7 0.02 5.40E-03 2.1
